Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
J. Peter Fasse is a principal in the Boston, MA, office of Fish & Richardson PC.
More GEN Content From This Contributor:
- Columns: Patent Eligibility of Biological Methods and Compositions
- GEN Exclusives: The USPTO's Current View on Patent Eligibility